UNSPSC 51123600: Antiarrythmic benzofurans

This classification denotes compounds that contain a benzene ring fused to a furan ring, substances which are therefore called benzo-furans, that prevent or treat irregular heartbeat, disturbances of normal rhythmic heart beating, or normal operation of myocardial contraction, thus the term ANTIARRYTHMIC BENZOFURANS.

UNSPSC 51123600 Antiarrhythmic benzofurans is a Class code under which state and local governments procure cardiac emergency medications—specifically antiarrhythmic agents and related Advanced Life Support drugs used by fire rescue services, public health agencies, and state pharmacy benefit programs. The work being solicited ranges from direct supply of finished medications in specific quantities and formulations to vendor participation in broader pharmaceutical network programs that aggregate demand across multiple state and local jurisdictions. Issuing bodies include municipal purchasing departments (city fire rescue services), state health and human services agencies managing pharmacy benefits, and multistate cooperative purchasing alliances that coordinate procurement across member states and local government facilities. Tampa Fire Rescue, the Texas Health and Human Services Commission, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) have all solicited under or related to this code in recent months, indicating activity across municipal emergency services, state benefits administration, and cooperative purchasing vehicles.

Recent solicitations show three distinct procurement models. The City of Tampa's sealed bid (26P00188), due April 8, 2026, sought 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials for Tampa Fire Rescue with a firm one-year term and optional two one-year renewals plus unilateral 30-day extensions; the estimated contract value was $40,000.00 and included a 5 percent bid discount for Small Local Business Enterprises. The Texas HHS Commission posted an exploratory Request for Information (RFI HHS0017013) in April 2026 to gather vendor capability data on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and wholesaler channels, signaling early-stage state-level interest in alternative supply models. The Minnesota Department of Administration's MMCAP issued a statewide RFP (S1070000015802) due March 26, 2026, to establish multi-award contracts for generic pharmaceuticals and OTC products distributed through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson) across participating state and local facilities including Oregon; the procurement weighted price competitiveness at 75 percent and required vendors to maintain relationships with at least two of the three authorized wholesalers with chargeback systems in place. Activity is concentrated in Florida, Texas, and Minnesota, with multistate reach through cooperative purchasing.